Matthew J. Higgins is an Associate Professor of Strategy and Innovation in the Scheller College of Business at the Georgia Institute of Technology and a Research Associate at the National Bureau of Economic Research (NBER). His research interests center primarily on firm responses to productivity changes (and challenges) and the performance implications of these decisions. This includes understanding the interrelationship between internal R&D and the use of external technology markets through acquisitions, alliances, licensing and corporate venture capital. Utilizing a novel risk model, this also includes whether firms are dynamically optimizing their R&D portfolios. Focusing on the external environment, Prof. Higgins is interested in the impact regulation has on innovation and productivity.
Most of his research has been conducted within the context of the pharmaceutical industry and has been published in a diverse range of leading journals including Science, Journal of Financial Economics, Review of Economics and Statistics, Strategic Management Journal and The RAND Journal of Economics. To date, Prof. Higgins has received over $3.5 million in funding and support from the Georgia Research Alliance, Kauffman Foundation, Rich Foundation, the National Institutes of Health (NIH), National Science Foundation (NSF), Pfizer Inc., and IMS Health, Inc. He is also the recipient of numerous teaching awards from the undergraduate, MBA and Executive MBA programs.